Press release
Peanut Allergy Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
Peanut Allergy Overview
Peanut allergy accounts for the majority of severe food-related allergic reactions. It tends to present early in life, and affected individuals generally do not outgrow it.
"Peanut Allergy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Peanut Allergy Market.
The Peanut Allergy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Peanut Allergy Pipeline Report: https://www.delveinsight.com/report-store/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Peanut Allergy treatment therapies with a considerable amount of success over the years. Peanut Allergy Key players such as - Allergy Therapeutics, Intrommune Therapeutics, InnoUp Farma, Cour Pharmaceutical, Vedanta Biosciences, Aravax, Prota Therapeutics, AstraZeneca, DBV technologies, Camallergy, Genentech, and others, are developing therapies for the Peanut Allergy treatment
• Peanut Allergy Emerging therapies such as - VLP Peanut, INT301, INP20, CNP-201, VE416, PVX-108, PRT100, Acalabrutinib, Viaskin Peanut, CA002, Omalizumab, and others are expected to have a significant impact on the Peanut Allergy market in the coming years.
• In June 2022, DBV Technologies announced positive topline results from Phase III EPITOPE Trial of Viaskin Peanut inPeanut-Allergic Toddlers
• In September 2022, the US Food and Drug Administration (FDA) has put a partial clinical hold on the phase III VITESSE(Viaskin Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy) clinical trial testing the efficacy and safety of epicutaneous immunotherapy with the modified Viaskin Peanut 250 µg patch in peanut-allergic children ages 4-7 year
• In December 2021, DBV Technologies announced that it has formally notified the European Medicines Agency (EMA) of its decision to withdraw the Marketing Authorization Application (MAA) for Viaskin Peanut
Route of Administration
Peanut Allergy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical
Molecule Type
Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Peanut Allergy Pipeline Therapeutics Assessment
• Peanut Allergy Assessment by Product Type
• Peanut Allergy By Stage and Product Type
• Peanut Allergy Assessment by Route of Administration
• Peanut Allergy By Stage and Route of Administration
• Peanut Allergy Assessment by Molecule Type
• Peanut Allergy by Stage and Molecule Type
DelveInsight's Peanut Allergy Report covers around 15+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Some of the key companies in the Peanut Allergy Therapeutics Market include:
Key companies developing therapies for Peanut Allergy are - Aimmune Therapeutics, Inc, Novartis Pharmaceuticals, DBV Technologies, InnoUp Farma S.L., COUR Pharmaceutical Development Company Inc, Vedanta Biosciences, Inc, Regeneron Pharmaceuticals, Genentech, Inc, Camallergy, Aravax, Inimmune, Prota therapeutics, Intrommune Therapeutics, Alladapt Immunotherapeutics, Siolta therapeutics, IgGenix and many others.
Emerging Peanut Allergy Drugs Under Different Phases of Clinical Development Include:
• VLP Peanut: Allergy Therapeutics
• INT301: Intrommune Therapeutics
• INP20: InnoUp Farma
• CNP-201: Cour Pharmaceutical
• VE416: Vedanta Biosciences
• PVX-108: Aravax
• PRT100: Prota Therapeutics
• Acalabrutinib: AstraZeneca
• Viaskin Peanut: DBV technologies
• CA002: Camallergy
• Omalizumab: Genentech
Get a Free Sample PDF Report to know more about Peanut Allergy Pipeline Therapeutic Assessment-
https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight
Peanut Allergy Pipeline Analysis:
The Peanut Allergy pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Peanut Allergy with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Peanut Allergy Treatment.
• Peanut Allergy key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Peanut Allergy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Peanut Allergy market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Further Peanut Allergy product details are provided in the report. Download the Peanut Allergy pipeline report to learn more about the emerging Peanut Allergy therapies at: https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Peanut Allergy Pipeline Market Drivers
• Increasing prevalence of peanut allergies
• Growth in commercial and scientific activities for research and development
Peanut Allergy Pipeline Market Barriers
• Lack of approved therapies
• Lack of public awareness of peanut allergy
• Accurate diagnosis of peanut allergy is critical.
Scope of Peanut Allergy Pipeline Drug Insight
• Coverage: Global
• Key Peanut Allergy Companies: Allergy Therapeutics, Intrommune Therapeutics, InnoUp Farma, Cour Pharmaceutical, Vedanta Biosciences, Aravax, Prota Therapeutics, AstraZeneca, DBV technologies, Camallergy, Genentech, and others
• Key Peanut Allergy Therapies: VLP Peanut, INT301, INP20, CNP-201, VE416, PVX-108, PRT100, Acalabrutinib, Viaskin Peanut, CA002, Omalizumab, and others
• Peanut Allergy Therapeutic Assessment: Peanut Allergy current marketed and Peanut Allergy emerging therapies
• Peanut Allergy Market Dynamics: Peanut Allergy market drivers and Peanut Allergy market barriers
Request for Sample PDF Report for Peanut Allergy Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1 Peanut Allergy Report Introduction
2 Peanut Allergy Executive Summary
3 Peanut Allergy Overview
4 Peanut Allergy- Analytical Perspective In-depth Commercial Assessment
5 Peanut Allergy Pipeline Therapeutics
6 Peanut Allergy Late Stage Products (Phase II/III)
7 Peanut Allergy Mid Stage Products (Phase II)
8 Peanut Allergy Early Stage Products (Phase I)
9 Peanut Allergy Preclinical Stage Products
10 Peanut Allergy Therapeutics Assessment
11 Peanut Allergy Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Peanut Allergy Key Companies
14 Peanut Allergy Key Products
15 Peanut Allergy Unmet Needs
16 Peanut Allergy Market Drivers and Barriers
17 Peanut Allergy Future Perspectives and Conclusion
18 Peanut Allergy Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report to know more about Peanut Allergy drugs and therapies- https://www.delveinsight.com/sample-request/peanut-allergy-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Related Reports:
Peanut Allergy Market https://www.delveinsight.com/report-store/peanut-allergy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Peanut Allergy-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Peanut Allergy Epidemiology https://www.delveinsight.com/report-store/peanut-allergy-pa-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Peanut Allergy Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Related Reports By DelveInsight -
Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Hypertrophic Scar Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hypertrophic Scar, historical and forecasted epidemiology as well as the Hypertrophic Scar market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Lung Fibrosis Market https://www.delveinsight.com/report-store/lung-fibrosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Lung Fibrosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lung Fibrosis, historical and forecasted epidemiology as well as the Lung Fibrosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Anterior Uveitis Market https://www.delveinsight.com/report-store/anterior-uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Anterior Uveitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Anterior Uveitis, historical and forecasted epidemiology as well as the Anterior Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
22q11.2 deletion syndrome Market https://www.delveinsight.com/report-store/22q112-deletion-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "22q11.2 Deletion Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the 22q11.2 Deletion Syndrome, historical and forecasted epidemiology as well as the 22q11.2 Deletion Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
X-Linked Retinitis Pigmentosa (XLRP) Market https://www.delveinsight.com/report-store/x-linked-retinitis-pigmentosa-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "X-Linked Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the X-Linked Retinitis Pigmentosa (XLRP), historical and forecasted epidemiology as well as the X-Linked Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peanut Allergy Pipeline Drugs and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here
News-ID: 2945395 • Views: …
More Releases from DelveInsight Business Research
Waldenstrom Macroglobulinemia Market Analysis 2034 - Competitive Landscape, Clin …
Waldenström macroglobulinemia (WM) is a rare, slow-developing non-Hodgkin lymphoma characterized by abnormal B-cell growth in the bone marrow and excessive production of IgM protein. In 2023, around 3,190 new cases were reported across the 7MM, with the US contributing about 40%. The disease is more common in males, and nearly half of cases occur in individuals over 65 due to genetic and age-related factors, including the MYD88 L265P mutation found…
Wilson's Disease Market Analysis 2034 - Competitive Landscape, Clinical Trials, …
DelveInsight reports that approximately 8,000 diagnosed prevalent cases of Wilson's Disease were recorded in the 7MM in 2023, with numbers projected to rise through 2034. The United States leads the market with a 2023 valuation of about USD 126 million, expected to grow at a CAGR of 13%. Current treatment mainly involves chelating agents and zinc salts, with chelating agents dominating the U.S. market at around USD 123 million. Recent…
Biktarvy Market and Sales Forecast: Strong Global Adoption, Expanding Indication …
DelveInsight, a leading business intelligence and market research firm, announced the publication of its latest report, "Biktarvy Market Insights, Sales Forecast, and Competitive Landscape - 2034." The report provides an in-depth commercial, clinical, and strategic outlook on Biktarvy® (bictegravir/emtricitabine/tenofovir alafenamide), reinforcing its continued leadership as one of the most widely prescribed HIV therapies worldwide.
As global healthcare systems increasingly adopt simplified antiretroviral regimens to improve adherence and long-term viral suppression, Biktarvy…
Global Biologics Contract Manufacturing Market to reach USD 47,494.63 million at …
According to DelveInsight's analysis, The increasing incidence of chronic conditions such as cancer, diabetes, and autoimmune diseases is driving the demand for biologic therapies, prompting pharmaceutical companies to outsource large-scale production to contract manufacturers. Additionally, the expanding pipeline of biologics-including monoclonal antibodies, vaccines, and biosimilars-necessitates adaptable manufacturing solutions to address rising market demand efficiently. Moreover, advancements in biotechnology and biomedical techniques, such as recombinant DNA technology and enhanced expression systems,…
More Releases for Peanut
Peanut Butter Market 2020-2027 Advance Study Focusing On Major Product Types- S …
Peanut Butter Market Overview 2020-2027:
Peanut butter market is anticipated to dominate the market with a market value of USD 4.20 billion in 2019 and is expected to grow with a growth rate of 6.10% in the forecast period of 2020 to 2027. The latest Market report by a Data Bridge Market Research with the title [Global Peanut Butter Market – Industry Trends and Forecast to 2027].
Get a PDF Sample copy (including COVID-19 impact analysis and up-to 30% discount ) @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-peanut-butter-market
In…
Peanut Butter Manufacturing Unit
Peanut butter is a high calorie, high protein product manufactured by grinding peanuts. It is a good alternative for dairy butter and widely used as a bread spread. Peanut butter is popular amongst Americans, and it is a part of their daily breakfast.
The demand for peanut butter is susceptible to consumer spending. As disposable income increases, the willingness of the people to purchase the peanut butter also increases. On…
Peanut Sauce Market 2019 | Worldwide Forecast 2025 | Major Players – Jif, PBfi …
Peanut Sauce Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/85716
UpMarketResearch offers a latest published report on “Global Peanut Sauce Market Analysis and Forecast 2019 - 2025” delivering key insights and providing a competitive advantage…
Drinkable Peanut Powder Market | Top Key Players are Golden Peanut and Tree Nuts …
Peanuts are a high-protein, nutritious food that are ready-to-eat with little preparation or can be eaten raw. Peanut can be processed by roasting and ground into various food products. Peanut shakes and smoothies segments are gaining significant traction in the global drinkable peanut powder market.
Rising demand for the healthy beverages such as drinkable peanut powder products driving the market. In addition, food manufacturers are developing peanut powder which is based…
Hormel Foods, J.M. Smucker Company, Saratoga Peanut Butter Company, Peanut Butte …
The market for Peanut Paste is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global Peanut Paste Market Insights, Forecast to 2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an…
Peanut Butter Market Report 2018: Segmentation by Product (Regular Peanut Butter …
Global Peanut Butter market research report provides company profile for Hormel Foods Corporation, Boulder Brands, Kraft Canada, Algood Food Company, Procter & Gamble, Unilever, The J.M. Smucker Company and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018…
